pharma · Schizophrenia · Narcolepsy Type 1
Alkermes Pharma Ireland
Alkermes Pharma Ireland patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Dublin, USA HQ
27 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Dublin, USA
- Employees
- 27
- Programs
- 1
- Drugs
- 1
- Patents
- 1
Alkermes Pharma Ireland patents
1 pharmaceutical patents indexed for Alkermes Pharma Ireland. 0 expire within 24 months.
Alkermes Pharma Ireland has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Alkermes Pharma Ireland have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Alkermes Pharma Ireland patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.